Euda Health Holdings Subsidiary Reports Sharp Decrease in Net Loss and Improved EPS for H1 2025
A subsidiary of EUDA Health Holdings Ltd. reported its financial results for the six months ended June 30, 2024. The subsidiary recorded revenue from external customers of $1,908,048 for the period, compared to no reported revenue in the same period of the previous year. The cost of revenue was $1,465,976, resulting in a segment gross profit of $442,072. The subsidiary reported a net loss of $16,748,274 for the six-month period, reflecting a substantial increase compared to a net loss of $1,201,696 in the same period of the prior year. The comprehensive loss for the period was $16,793,161, up from $1,176,581 in the previous year's comparable period. No significant updates regarding business operations were disclosed in the reported results.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Euda Health Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016547), on October 01, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。